MEI Pharma, Inc.

NasdaqCM:MEIP 주식 보고서

시가총액: US$19.3m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

MEI Pharma 관리

관리 기준 확인 2/4

현재 CEO에 대한 정보가 충분하지 않습니다.

주요 정보

Jay File

최고 경영자

US$655.7k

총 보상

CEO 급여 비율68.6%
CEO 임기1.1yrs
CEO 소유권n/a
경영진 평균 재임 기간2yrs
이사회 평균 재임 기간3.8yrs

최근 관리 업데이트

Recent updates

New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)

Feb 17
New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)

Increases to CEO Compensation Might Be Put On Hold For Now at MEI Pharma, Inc. (NASDAQ:MEIP)

Dec 30
Increases to CEO Compensation Might Be Put On Hold For Now at MEI Pharma, Inc. (NASDAQ:MEIP)

Need To Know: Analysts Are Much More Bullish On MEI Pharma, Inc. (NASDAQ:MEIP)

Nov 19
Need To Know: Analysts Are Much More Bullish On MEI Pharma, Inc. (NASDAQ:MEIP)

We're Hopeful That MEI Pharma (NASDAQ:MEIP) Will Use Its Cash Wisely

May 18
We're Hopeful That MEI Pharma (NASDAQ:MEIP) Will Use Its Cash Wisely

Need To Know: The Consensus Just Cut Its MEI Pharma, Inc. (NASDAQ:MEIP) Estimates For 2022

Mar 26
Need To Know: The Consensus Just Cut Its MEI Pharma, Inc. (NASDAQ:MEIP) Estimates For 2022

Newsflash: MEI Pharma, Inc. (NASDAQ:MEIP) Analysts Have Been Trimming Their Revenue Forecasts

Feb 12
Newsflash: MEI Pharma, Inc. (NASDAQ:MEIP) Analysts Have Been Trimming Their Revenue Forecasts

MEI Pharma: Another PI3K Delta Progressing To The FDA

Feb 01

Need To Know: Analysts Just Made A Substantial Cut To Their MEI Pharma, Inc. (NASDAQ:MEIP) Estimates

Dec 02
Need To Know: Analysts Just Made A Substantial Cut To Their MEI Pharma, Inc. (NASDAQ:MEIP) Estimates

We're Not Very Worried About MEI Pharma's (NASDAQ:MEIP) Cash Burn Rate

Nov 04
We're Not Very Worried About MEI Pharma's (NASDAQ:MEIP) Cash Burn Rate

MEI Pharma EPS misses by $0.12, misses on revenue

May 06

MEI Pharma promotes Richard Ghalie to chief medical officer

Apr 30

MEI Pharma shares rise 4% as Wells Fargo says voruciclib undervalued

Apr 26

The Independent Non-Executive Director of MEI Pharma, Inc. (NASDAQ:MEIP), Frederick Driscoll, Just Sold 40% Of Their Holding

Feb 25
The Independent Non-Executive Director of MEI Pharma, Inc. (NASDAQ:MEIP), Frederick Driscoll, Just Sold 40% Of Their Holding

New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)

Feb 11
New Forecasts: Here's What Analysts Think The Future Holds For MEI Pharma, Inc. (NASDAQ:MEIP)

CEO 보상 분석

Jay File 의 보수는 MEI Pharma 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jun 30 2024US$656kUS$450k

US$18m

보상 대 시장: Jay 의 총 보상 ($USD 655.65K )은 US 시장에서 비슷한 규모의 회사의 평균 수준입니다( $USD 667.49K ).

보상과 수익: Jay 의 보상을 회사 성과와 비교하기에는 데이터가 부족합니다.


CEO

Jay File (54 yo)

1.1yrs

테뉴어

US$655,650

보상

Mr. Justin J. File, also known as Jay, serves as CFO & Corporate Secretary at MEI Pharma, Inc. since August 01, 2023 and serves as its Acting Chief Executive Officer from August 01, 2024. He had been an Ex...


리더십 팀

이름위치테뉴어보상소유권
Justin File
Acting CEO1.1yrsUS$655.65k데이터 없음
Yomara Gomez-Naiden
Senior Vice President of Operations & Quality1.2yrs데이터 없음데이터 없음
Nicole Iida
Vice President of Legal Affairs1.7yrs데이터 없음데이터 없음
Anne Frese
Chief People Officer2.3yrs데이터 없음데이터 없음
Robert Mass
Strategic Advisor13.3yrsUS$755.98k데이터 없음
David Walsey
Senior Vice President of Corporate Affairs3.3yrs데이터 없음데이터 없음

2.0yrs

평균 재임 기간

경험이 풍부한 관리: MEIP 의 관리팀은 경험 (평균 재직 기간 1.7 년)으로 간주되지 않으므로 새로운 팀을 추천합니다.


이사회 구성원

이름위치테뉴어보상소유권
Frederick Driscoll
Independent Chairperson6.6yrsUS$117.20k0.028%
$ 5.4k
Nicholas Glover
Independent Non-Executive Director11.3yrsUS$122.78k0%
$ 0
Thomas Reynolds
Independent Non-Executive Director11.6yrsUS$115.28k0.0075%
$ 1.4k
Steven Wood
Independent Non-Executive Directorless than a yearUS$112.40k0.14%
$ 27.1k
James Flynn
Independent Directorless than a yearUS$114.07k0.12%
$ 22.9k
Taheer Datoo
Directorless than a yearUS$68.06k데이터 없음

3.8yrs

평균 재임 기간

49yo

평균 연령

경험이 풍부한 이사회: MEIP 의 이사회경험(평균 재직 기간 3.7 년)으로 간주됩니다.